Detailed information for compound 368472

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 555.59 | Formula: C24H24F3N3O5S2
  • H donors: 1 H acceptors: 5 LogP: 4.36 Rotable bonds: 12
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCC(=O)OCc1cc(ccc1S(=O)(=O)NC(=O)CC)n1nc(cc1c1ccc(cc1)SC)C(F)(F)F
  • InChi: 1S/C24H24F3N3O5S2/c1-4-22(31)29-37(33,34)20-11-8-17(12-16(20)14-35-23(32)5-2)30-19(13-21(28-30)24(25,26)27)15-6-9-18(36-3)10-7-15/h6-13H,4-5,14H2,1-3H3,(H,29,31)
  • InChiKey: IJOQAHXQQZLVIV-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Chlamydia trachomatis methionine aminopeptidase 0.0043 0 0.5
Trichomonas vaginalis Clan MG, familly M24, aminopeptidase P-like metallopeptidase 0.0099 1 0.5
Loa Loa (eye worm) initiation factor 2-associated protein 0.0099 1 1
Giardia lamblia Methionine aminopeptidase 0.0099 1 0.5
Trypanosoma cruzi metallo-peptidase, Clan MG, Family M24 0.0099 1 1
Trypanosoma brucei methionine aminopeptidase 2, putative 0.0099 1 1
Treponema pallidum methionine aminopeptidase (map) 0.0043 0 0.5
Plasmodium vivax methionine aminopeptidase 1b, putative 0.0061 0.3151 0.3151
Leishmania major methionine aminopeptidase 2, putative 0.0099 1 1
Mycobacterium tuberculosis Methionine aminopeptidase MapB (map) (peptidase M) 0.0043 0 0.5
Entamoeba histolytica methionine aminopeptidase, putative 0.0099 1 0.5
Echinococcus multilocularis methionyl aminopeptidase 1 (M24 family) 0.0061 0.3151 0.3151
Mycobacterium ulcerans methionine aminopeptidase 0.0043 0 0.5
Mycobacterium leprae PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) 0.0043 0 0.5
Onchocerca volvulus Methionine aminopeptidase 2 homolog 0.0099 1 0.5
Mycobacterium leprae PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) 0.0043 0 0.5
Toxoplasma gondii methionine aminopeptidase 2, putative 0.0099 1 1
Plasmodium falciparum methionine aminopeptidase 2 0.0099 1 1
Toxoplasma gondii methionine aminopeptidase 0.0061 0.3151 0.3151
Trichomonas vaginalis Clan MG, familly M24, aminopeptidase P-like metallopeptidase 0.0099 1 0.5
Echinococcus granulosus methionyl aminopeptidase 2 0.0099 1 1
Trypanosoma cruzi metallo-peptidase, Clan MG, Family M24 0.0099 1 1
Schistosoma mansoni methionyl aminopeptidase 2 (M24 family) 0.0099 1 1
Plasmodium vivax methionine aminopeptidase 2, putative 0.0099 1 1
Mycobacterium ulcerans methionine aminopeptidase MapB 0.0043 0 0.5
Wolbachia endosymbiont of Brugia malayi methionine aminopeptidase 0.0043 0 0.5
Trichomonas vaginalis Clan MG, familly M24, aminopeptidase P-like metallopeptidase 0.0099 1 0.5
Mycobacterium tuberculosis Methionine aminopeptidase MapA (map) (peptidase M) (MetAP) 0.0043 0 0.5
Echinococcus multilocularis methionyl aminopeptidase 2 0.0099 1 1
Trypanosoma brucei metallo-peptidase, Clan MG, Family M24 0.0099 1 1
Plasmodium falciparum methionine aminopeptidase 1b, putative 0.0061 0.3151 0.3151
Trichomonas vaginalis Clan MG, familly M24, aminopeptidase P-like metallopeptidase 0.0099 1 0.5

Activities

Activity type Activity value Assay description Source Reference
ED50 (functional) = 38 mg kg-1 Anti-inflammatory activity in orally dosed Wistar rat assessed as reduction of carrageenan-induced paw edema at 30 mg/kg, po ChEMBL. 16730986
Inhibition (binding) = 0 % Inhibition of microsomal COX1 at 10 uM ChEMBL. 16730986
Inhibition (binding) = 0 % Inhibition of microsomal COX1 at 10 uM ChEMBL. 16730986
Inhibition (binding) = 18 % Inhibition of human recombinant COX2 expressed in sf9 cells infected with baculovirus at 10 uM ChEMBL. 16730986
Inhibition (binding) = 18 % Inhibition of human recombinant COX2 expressed in sf9 cells infected with baculovirus at 10 uM ChEMBL. 16730986

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.